Search Results from ClinicalConnection

71 studies found

The FINISH Study is a 7-week research study to evaluate the safety of an investigational drug to treat bipolar disorder for children and teens aged 10-17. Those qualified will receive study medicatio

The purpose of the PARALLAX Study is to measure the safety and tolerability of an injectable study drug and its effects on calcium levels in the blood and the amount of calcium passed in the urine, i

The purpose of PILLAR, a Phase 4 clinical trial, is to see if an FDA-approved prescription medicine called MYRBETRIQ (mirabegron) is both effective and safe as a treatment for Overactive Bladder (OA